Saturday, May 06, 2017 10:28:21 AM
It's great that Germany is progressing. However, I never hear anything about any other country. If you look at the Registry, the only country that is growing is Germany. I asked Dr. Chan a while ago how our sales force is progressing in other countries. I see no movement or growth on the Registry. Why are they not growing? Why can't we expand our sales team? How long does it take, on average, to get into a hospital and get buy-in from them? What is the process? How many sales people do we have dedicated to each country? This is why things take so long. The focus is Germany. It will take years and years to grow these other countries without an extensive sales force.
I know we have Fresenius and Terumo. I'm just waiting for something to pop with them. It's been too many years for Fresenius. Why aren't they making more of a move with CTSO??? Hoping these 2 companies can expedite our growth. we certainly can't go at it along. And where is Biocon? Holy cow! Everyone was so excited to have them on board. they have been a complete flop.
I think Zack's estimates are pretty on target right now unless one of these companies strikes a deal with us. I think Q1 will be at $3M...nothing more. This is nice growth but not where we need to be at this stage of the company's life.
Oh, and where is Canada in this process? Why can't we get an update from them? Even if we get approval from Canada tomorrow, revenue won't take off for years. Back to my questions to DC above. How long does it take, on average, to get into hospitals, run through training, and begin ramping up revenue? I'm thinking somewhere around 8-12 months. Look at how long they have been in Germany? They just hit their first $1M hospital. I want to know how long they have been working with this hospital.
This stock has no following. Why???? I agree with a lot that DC needs to bring in someone with a better sense on how to grow the stock price and earnings. We stumbled big time about 3 years ago with this product. Our sales should be a lot higher than they are right now. I attribute this to a lack of planning and insight from management. The fact that we are at $10M right now is ridiculous. If things would have gone right, we should be at $30M-$40M easily right now. Zack's estimate doesn't get us there until 2020.
There are a lot of questions to be answered by DC. I have more than a fortune tied up in this company. DC refuses to answer a lot of my questions. My next step is the Board. After that, I will be asking for support from the shareholders. Maybe collectively, we can get this company back on track.
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM